May 06, 2021
×
The real deal will be when negotiations eventually begin to frame the context within which waivers are allowed
The public health universe has been abuzz ever since the US administration expressed its support to a waiver proposal on Covid-19 vaccines.
The proposal initially made by India and South Africa at the World Trade Organization (WTO) involved temporarily suspending intellectual property (IP) on Covid-19 linked medicines, diagnostics and vaccines, for the pandemic period. And it still requires support from all other WTO members.
‘Clarity’
The “real deal”, though, will be when negotiations eventually begin to frame the context within which waivers are allowed and outlining for how long it would be allowed, say IP experts. Clarity is also required on whether this support is only for vaccines or for other health technologies as well.
Text Size:
A+
New Delhi: For months, developed economies have hoarded Covid-19 vaccines and the raw materials needed to make them. Now, they’re being forced to act as an explosive outbreak in India raises the risk of new virus mutations that could threaten the wider world.
Under mounting criticism for dominating vaccine resources, the U.S. said this week that it will help India by sending items needed to manufacture vaccines as part of an aid package. European countries are also pledging help as new cases in the South Asian country smash world records. President Joe Biden’s administration is separately vowing to share its stockpile of AstraZeneca Plc vaccines which the U.S. hasn’t even approved for use and meeting with drug companies about boosting supply and waiving intellectual property protections on Covid-19 shots, a shift India and South Africa have been pushing for.
Apr 28, 2021
For months, developed economies have hoarded COVID-19 vaccines and the raw materials needed to make them. Now, they’re being forced to act as an explosive outbreak in India raises the risk of new virus mutations that could threaten the wider world.
Under mounting criticism for dominating vaccine resources, the U.S. said this week that it will help India by sending items needed to manufacture vaccines as part of an aid package. European countries are also pledging help as new cases in the South Asian country smash world records. U.S. President Joe Biden’s administration is separately vowing to share its stockpile of AstraZeneca PLC vaccines which the U.S. hasn’t even approved for use and meeting with drug companies about boosting supply and waiving intellectual property protections on COVID-19 shots, a shift India and South Africa have been pushing for.
Vaccine Hoarding May Backfire On Nations As India s Surge Threatens World ndtv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ndtv.com Daily Mail and Mail on Sunday newspapers.
Health experts now see a ramped up vaccination effort as key to quelling second Covid wave in India.
NEW DELHI: For months, developed economies have hoarded Covid-19 vaccines and the raw materials needed to make them. Now, they’re being forced to act as an explosive outbreak in India raises the risk of new virus mutations that could threaten the wider world.
Under mounting criticism for dominating vaccine resources, the US said this week that it will help India by sending items needed to manufacture vaccines as part of an aid package. European countries are also pledging help as new cases in the South Asian country smash world records. President Joe Biden’s administration is separately vowing to share its stockpile of AstraZeneca Plc vaccines which the US hasn’t even approved for use and meeting with drug companies about boosting supply and waiving intellectual property protections on Covid-19 shots, a shift India and South Africa have been pushing for.